Form 4: Edgewell Director Receives Equity Grant
Insider Transaction Report
Edgewell Personal Care Co. Director John C Hunter III was granted 7,817 restricted stock equivalents, aligning his interests with shareholders.
Summary
- John C Hunter III, a Director of Edgewell Personal Care Co. (EPC), acquired 7,817 Restricted Stock Equivalents.
- The transaction date for this acquisition was February 5, 2026.
- These Restricted Stock Equivalents convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders.
- The Reporting Person has the option to defer conversion until the termination of service on Edgewell's Board of Directors.
- Following this transaction, John C Hunter III beneficially owns 7,817 derivative securities.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a slightly positive, routine event. While not a major catalyst, it signifies continued director engagement and alignment with shareholder interests, which is generally favorable.
Positives
- The grant of restricted stock equivalents to a director increases their equity stake in the company, fostering stronger alignment of interests with long-term shareholders.
Future Outlook
The filing does not contain specific forward-looking statements or guidance beyond the conversion terms of the restricted stock equivalents.
Industry Context
StockSavvy.ai notes that granting equity-based compensation, such as restricted stock equivalents, to non-employee directors is a common practice across various industries. This method is widely used to attract and retain qualified board members while aligning their financial incentives with the company's performance and shareholder value creation.
Comparison to Industry Standards
- Equity compensation for non-employee directors, including restricted stock units or equivalents, is a standard practice across publicly traded companies, including peers in the consumer goods sector like Procter & Gamble (PG) or Kimberly-Clark (KMB).
- The structure, where conversion is tied to an annual meeting or termination of service, is typical for such grants, ensuring continued engagement and long-term perspective from board members.
Stakeholder Impact
- Shareholders: The grant aligns the director's financial interests with those of the shareholders, potentially encouraging decisions that enhance long-term shareholder value.
Next Steps
- The Restricted Stock Equivalents will convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders, unless the Reporting Person elects to defer conversion until termination of service.
Key Dates
| Date | Description |
|---|---|
| 02/05/2026 | Transaction date for the acquisition of Restricted Stock Equivalents by Director John C Hunter III. |
| 02/06/2026 | Date the Statement of Changes in Beneficial Ownership (Form 4) was signed and filed. |
Keywords
Edgewell Personal Care, EPC, Form 4, Insider Transaction, Restricted Stock Equivalents, Director Compensation, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.